share_log

歌禮製藥-B：翌日披露報表

ASCLETIS-B: Next Day Disclosure Return

香港交易所 ·  Feb 2 04:59
Summary by Moomoo AI
歌禮製藥有限公司於2024年2月2日向香港聯合交易所有限公司提交了翌日披露報表，披露其股份購回情況。根據報表，該公司在2023年12月19日至2024年2月2日期間，進行了多次股份購回活動，但並未註銷這些股份。最後一次購回發生在2024年2月2日，當日購回500,000股，佔已發行股份的0.0479%。該次購回的股份總數為500,000股，總金額為856,010港元，每股價格介於1.66港元至1.78港元之間。自普通決議案通過以來，公司在香港聯交所購回的證券總數為62,871,000股，佔當時已發行股份的5.7832%。
歌禮製藥有限公司於2024年2月2日向香港聯合交易所有限公司提交了翌日披露報表，披露其股份購回情況。根據報表，該公司在2023年12月19日至2024年2月2日期間，進行了多次股份購回活動，但並未註銷這些股份。最後一次購回發生在2024年2月2日，當日購回500,000股，佔已發行股份的0.0479%。該次購回的股份總數為500,000股，總金額為856,010港元，每股價格介於1.66港元至1.78港元之間。自普通決議案通過以來，公司在香港聯交所購回的證券總數為62,871,000股，佔當時已發行股份的5.7832%。
ACEA PHARMACEUTICALS LIMITED FILED THE FOLLOWING DAY DISCLOSURE REPORT WITH THE HONG KONG STOCK EXCHANGE LIMITED ON FEBRUARY 2, 2024 DISCLOSING THE REPURCHASE STATUS OF ITS SHARES. According to the report, the company conducted several share repurchases between December 19, 2023 and February 2, 2024, but did not write them off. The last repurchase took place on February 2, 2024, and repurchased 500,000 shares on the same day, representing 0.0479% of the issued shares. The total number of shares repurchased is 500,000 shares for a total amount of HK$856,010, priced between HK$1.66 and HK$1.78 per share. Since the adoption of the Ordinary Resolution, the Company has repurchased 62,871,000 shares on the Hong Kong Stock Exchange, representing 5.7832% of the shares issued at that time.
ACEA PHARMACEUTICALS LIMITED FILED THE FOLLOWING DAY DISCLOSURE REPORT WITH THE HONG KONG STOCK EXCHANGE LIMITED ON FEBRUARY 2, 2024 DISCLOSING THE REPURCHASE STATUS OF ITS SHARES. According to the report, the company conducted several share repurchases between December 19, 2023 and February 2, 2024, but did not write them off. The last repurchase took place on February 2, 2024, and repurchased 500,000 shares on the same day, representing 0.0479% of the issued shares. The total number of shares repurchased is 500,000 shares for a total amount of HK$856,010, priced between HK$1.66 and HK$1.78 per share. Since the adoption of the Ordinary Resolution, the Company has repurchased 62,871,000 shares on the Hong Kong Stock Exchange, representing 5.7832% of the shares issued at that time.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more